October 28, 2016 1:29 PM ET


Company Overview of Eurand N.V.

Company Overview

As of February 11, 2011, Eurand N.V. was acquired by Aptalis Pharma Inc. Eurand N.V. develops, manufactures, and commercializes pharmaceutical and biopharmaceutical products. Its technologies are used for applications in drug products in a range of therapeutic areas, including cardiovascular, gastrointestinal, pain, nutrition, and respiratory. The company’s products include EUR-1008, or ZENPEP for the treatment of exocrine pancreatic insufficiency; EUR-1002 or Amrix, an adjunct to rest and physical therapy for relief of muscle spasm associated with acute painful musculoskeletal conditions; EUR-1048 or Lamictal ODT, an orally disintegrating tablet formulation of lamotrigine for the treatment ...

Olympic Plaza

Fred Roeskestraat 123

Amsterdam,  1076 EE


Founded in 1984

583 Employees


31 20 673 2744

Key Executives for Eurand N.V.

Eurand N.V. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
All-Gen Pharmaceuticals and Generics B.V. Europe
Alzheimer Research Centrum BV Europe
Angita B.V. Europe
AquaCultura B.V. Europe
Arcarios B.V. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eurand N.V., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.